Skip to content

Drug interactions

Dipyridamole + Safinamide

Severity: Minor

Dipyridamole and Safinamide: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Safinamide and its main metabolite can inhibit intestinal BCRP, which may increase the absorption of BCRP substrates. Dipyridamole is not a well-established BCRP substrate, so any increase in its effect is speculative and likely small.

What this interaction means in plain words

Dipyridamole and Safinamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dipyridamole belongs to Cardiovascular; Safinamide belongs to Central Nervous System.

Evidence level: Low

Why it happens

Possible inhibition of intestinal BCRP efflux by safinamide, leading to higher exposure to substrates.

What to do

No dose change is expected; monitor for dipyridamole adverse effects such as headache, dizziness or hypotension if the combination is started.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dipyridamole and Safinamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dipyridamole with Safinamide?

MediHelp rates the interaction as minor. Dipyridamole and Safinamide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Safinamide and its main metabolite can inhibit intestinal BCRP, which may increase the absorption of BCRP substrates. Dipyridamole is not a well-established BCRP substrate, so any increase in its effect is speculative and likely small.

How serious is the interaction between Dipyridamole and Safinamide?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is expected; monitor for dipyridamole adverse effects such as headache, dizziness or hypotension if the combination is started.

What other medicines interact with Dipyridamole?

MediHelp also lists interactions of Dipyridamole with, for example, Riociguat, Adenosine, Betrixaban. The full list is on the Dipyridamole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in